Suki, a company offering AI voice solutions to healthcare companies, has secured $70 million in Series D funding, it announced Thursday. The financing will help the company build new products.

Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company whose lead asset is in late-stage clinical ...

The fee-for-service (FFS) payment model that has been the norm in healthcare for decades may finally be on its way out, with many physicians and hospital leaders leaning into value-based care (VBC).

Rural Americans have long experienced poorer health outcomes compared to their urban counterparts. New evidence shows that the divide is widening, with rural adults aged 25 to 54 significantly ...

Last year, researchers looked at the directories of the nation’s five largest health plans and found that four out of five entries were inaccurate. This is more than a minor inconvenience.

Depression, a common yet complex mental health issue, affects millions worldwide. Despite its prevalence and long clinical history, treating depression remains fraught with challenges. A diagnosis ...

HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI, the shifting landscapes of telemedicine ...

Ashley Tyrner has gone from being a single mom on food stamps where she experienced firsthand life as an economically disadvantaged minority to the founder and CEO of FarmboxRx – a leading food ...

Phil Galewitz covers Medicaid, Medicare, long-term care, hospitals and various state health issues. He has covered the health beat for nearly two decades. He is a board member of the Association ...

Dr. Barlow’s experience spans various facets of healthcare, from Emergency Room Medical Director to Senior White House Physician, to CMO at the nation’s largest urgent care provider.

Jeff Fuller is the Vice President of Analytics Solutions at CipherHealth – a leading healthcare technology company creating innovative patient engagement solutions that improve communication and ...

The FDA approved Servier Pharmaceuticals’ Voranigo as a treatment for two types of low-grade gliomas. The drug, which is projected to become a blockbuster product, comes from Servier’s $1.8 ...